Your browser doesn't support javascript.
loading
Bone Mineral Density Response With Denosumab in Combination With Standard or High-Dose Teriparatide: The DATA-HD RCT.
Ramchand, Sabashini K; David, Natalie L; Leder, Benjamin Z; Tsai, Joy N.
Affiliation
  • Ramchand SK; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA.
  • David NL; Department of Medicine, Endocrine Unit, Austin Hospital, The University of Melbourne, Victoria, Australia.
  • Leder BZ; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA.
  • Tsai JN; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA.
J Clin Endocrinol Metab ; 105(3)2020 03 01.
Article in En | MEDLINE | ID: mdl-31674641
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Density / Osteoporosis, Postmenopausal / Teriparatide / Bone Density Conservation Agents / Denosumab Type of study: Clinical_trials / Diagnostic_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 2020 Document type: Article Affiliation country: Marruecos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Density / Osteoporosis, Postmenopausal / Teriparatide / Bone Density Conservation Agents / Denosumab Type of study: Clinical_trials / Diagnostic_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 2020 Document type: Article Affiliation country: Marruecos